The additions included companies that are customers of Intel and Nvidia, and one firm that was the focus of a New York Times ...
DeepSeek briefly crashed Nvidia’s stock because of speculation that its models require far fewer chips. Now, Chinese fintech ...
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results